Table 5.
Projected number of other adults 50 years and older with chronic disease (in millions by sex and age) in the United States.
| Age cohort | 2020 | 2035 | 2050 | Relative change between 2020 and 2050 (%) |
|---|---|---|---|---|
| ≥1 chronic disease (million) | ||||
| 50–59 years | 1.0999 [0.9828–1.1846] |
1.2283 [1.0907–1.3279] |
1.5519 [1.3788–1.6769] |
41.10% [40.29%−41.56%] |
| 60–79 years | 3.0872 [2.8448–3.3042] |
4.8468 [4.2676–5.3310] |
5.7521 [5.0644–6.3334] |
86.32% [78.02%−91.68%] |
| 80 and older | 0.7201 [0.5662–0.8631] |
1.7029 [1.1205–2.3582] |
2.3800 [1.4159–3.6244] |
230.5% [150.1%−319.9%] |
| Total | 4.9072 [4.3938–5.3519] |
7.778 [6.4788–9.0171] |
9.684 [7.8591–11.6347] |
97.34% [78.87%−117.4%] |
| Female | ||||
| 50–59 years | 0.5487 [0.4836–0.5946] |
0.6086 [0.5328–0.6619] |
0.7583 [0.6642–0.8245] |
38.19% [37.33%−38.66%] |
| 60–79 years | 1.5952 [1.4542–1.7136] |
2.5305 [2.2494–2.7866] |
2.9676 [2.6363–3.2725] |
86.03% [81.28%−90.97%] |
| 80 and older | 0.4340 [0.3396–0.5224] |
1.0081 [0.6614–1.3750] |
1.4154 [0.8355–2.1206] |
226.1% [146.1%−305.9%] |
| Male | ||||
| 50–59 years | 0.5511 [0.4992–0.5923] |
0.6198 [0.5579–0.6688] |
0.7936 [0.7146–0.8560] |
43.99% [43.16%−44.51%] |
| 60–79 years | 1.4920 [1.3693–1.5906] |
2.3163 [2.0182–2.5507] |
2.7844 [2.4282–3.0656] |
86.63% [77.33%−92.73%] |
| 80 and older | 0.2861 [0.2266–0.3423] |
0.6948 [0.4591–0.9844] |
0.9646 [0.5804–1.5037] |
237.2% [156.2%−339.3%] |
| Multimorbidity (million) | ||||
| 50–59 years | 0.1103 [0.0614–0.1523] |
0.1231 [0.0693–0.1695] |
0.1555 [0.0871–0.2146] |
40.98% [41.78%−40.89%] |
| 60–79 years | 0.3176 [0.1315–0.4941] |
0.4458 [0.1377–0.8072] |
0.5289 [0.1653–0.9555] |
66.51% [2.74%−93.39%] |
| 80 and older | 0.0840 [0.0304–0.1709] |
0.1584 [0.0335–0.4794] |
0.2083 [0.0369–0.7504] |
148.0% [21.5%−339.1%] |
| Total | 0.5119 [0.2233–0.8173] |
0.7273 [0.2405–1.4561] |
0.8927 [0.2893–1.9205] |
74.39% [29.56%−134.9%] |
| Female | ||||
| 50–59 years | 0.0498 [0.0270–0.0723] |
0.0552 [0.0301–0.0800] |
0.0688 [0.0373–0.0999] |
38.01% [38.28%−38.12%] |
| 60–79 years | 0.1493 [0.0611–0.2508] |
0.2125 [0.0635–0.4316] |
0.2487 [0.0749–0.5054] |
66.63% [22.70%−101.5%] |
| 80 and older | 0.0478 [0.0172–0.0957] |
0.0890 [0.0185–0.2656] |
0.1175 [0.0201–0.4220] |
145.9% [16.7%−341.1%] |
| Male | ||||
| 50–59 years | 0.0605 [0.0345–0.0807] |
0.0678 [0.0392–0.0910] |
0.0867 [0.0498–0.1165] |
43.42% [44.52%−44.43%] |
| 60–79 years | 0.1683 [0.0704–0.2506] |
0.2332 [0.0742–0.4081] |
0.2801 [0.0904–0.4886] |
66.41% [28.38%−94.96%] |
| 80 and older | 0.0362 [0.0132–0.0752] |
0.0695 [0.0150–0.2137] |
0.0908 [0.0168–0.3283] |
150.8% [27.8%−336.5%] |